Source: Annual Congress 2010 - Aspects of severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Simakova, Z. Mironova, V. Trofimov, V. Belash, E. Iantchina, M. Dubina (St. Petersburg, Russian Federation). Pharmacogenetic markers of steroid dependent bronchial asthma (BA) control. Eur Respir J 2010; 36: Suppl. 54, 5485

Member's Comments

No comment yet.

Related content which might interest you: Pharmacogenetic control of bronchial obstruction in steroid depend asthma (SDBA) patients Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011 Comparative characteristics of regulatory T cells populations between patients with bronchial asthma (BA) and COPD Source: Annual Congress 2011 - T-cell subsets Year: 2011 Genetic markers of bronchial asthma (BA) in BA females and their kids Source: Eur Respir J 2005; 26: Suppl. 49, 682s Year: 2005 E-cadherin (CDH-1) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS) Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010 A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Influence of ADRB2 gene polymorphism on cold airway hyperresponsiveness and asthma control depending on inhaled glucocorticoids use Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients Source: Annual Congress 2011 - Asthma: a heterogeneous disease Year: 2011 Effect of montelukast (ML) of an additional therapy in steroid dependent children with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003 Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol Source: International Congress 2019 – Airway physiology Year: 2019 Absence of nonspecific bronchial responsiveness (NSBR) in occupational asthma (OA): A case-series study Source: Annual Congress 2012 - Occupational asthma Year: 2012 Prediction of deterioration of bronchial asthma (BA) control after six months of basic anti-inflammatory therapy Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Low level of FoxP3 in bronchial asthma (BA) is associated with frequent exacerbations Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Relationship between salivary markers of oxidative stress (OS) and different levels of control of bronchial asthma (BA). Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Comparison of fluticasone propionate + salmeterol (FP+S) and montelukast (MK) on bronchial reactivity (BR), pulmonary function (PF) and clinical outcome in children with mild asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003 Budesonid/formoterol easyhaler: clinical efficiency and adherence to treatment in patients with partly controlled bronchial asthma (BA). Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Sputum tumour necrosis factorα (TNFα) levels in steroid dependent asthma (SDA) compared with COPD and normal controls Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001 Clinical and inflammatory determinants of (the course of) bronchial hyperresponsiveness in COPD Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids Source: Eur Respir J 2011; 38: 1044-1052 Year: 2011 Effects of β2 agonists on mucociliary clearance (MCC) in patients with asthma - association to polymorphisms of the β2-adrenoceptor Source: Eur Respir J 2003; 22: Suppl. 45, 478s Year: 2003